Refining Liver Safety Risk Assessment: Application of Mechanistic Modeling and Serum Biomarkers to Cimaglermin Alfa (GGF2) Clinical Trials-Reference-Cited by-同舟云学术

Refining Liver Safety Risk Assessment: Application of Mechanistic Modeling and Serum Biomarkers to Cimaglermin Alfa (GGF2) Clinical Trials

Published:2017-05-27 Issue:6 Volume:102 Page:961-969
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin. Pharmacol. Ther.

Author:

Longo DM¹,Generaux GT¹,Howell BA¹,Siler SQ¹,Antoine DJ²,Button D³,Caggiano A³,Eisen A³,Iaci J³,Stanulis R³,Parry T³,Mosedale M⁴⁵,Watkins PB⁴⁵

Affiliation:

1. DILIsym Services Inc.; Research Triangle Park North Carolina USA

2. MRC Centre for Drug Safety Science, Department of Molecular & Clinical Pharmacology; Liverpool University; Liverpool UK

3. Acorda Therapeutics Inc.; New York New York USA

4. Institute for Drug Safety Sciences; University of North Carolina at Chapel Hill; Chapel Hill North Carolina USA

5. Division of Pharmacotherapy and Experimental Therapeutics; UNC Eshelman School of Pharmacy; Chapel Hill North Carolina USA

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cpt.711/fullpdf

Reference34 articles.

1. Clinical , P. Guidance for Industry Drug-Induced Liver Injury? Premarketing Clinical Evaluation Guidance for Industry Drug-Induced Liver Injury? Premarketing Clinical Evaluation 2009

2. Hy's Law: predicting serious hepatotoxicity.;Temple;Pharmacoepidemiol. Drug Saf.,2006

3. Recent advances in biomarkers and therapeutic interventions for hepatic drug safety - false dawn or new horizon?;Clarke;Expert Opin. Drug Saf.,2016

4. Differentiation between cell death modes using measurements of different soluble forms of extracellular cytokeratin 18 differentiation between cell death modes using measurements of different soluble forms of extracellular cytokeratin 18.;Kramer;Cancer Res.,2004

5. CSF1 restores innate immunity after liver injury in mice and serum levels indicate outcomes of patients with acute liver failure;Stutchfield;Gastroenterology,2015

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Combination of a Human Biomimetic Liver Microphysiology System with BIOLOGXsym, a Quantitative Systems Toxicology (QST) Modeling Platform for Macromolecules, Provides Mechanistic Understanding of Tocilizumab- and GGF2-Induced Liver Injury;International Journal of Molecular Sciences;2023-06-02

2. Safety, Tolerability, and Pharmacokinetics of Recombinant Human Neuregulin-1 in Healthy Chinese Subjects;American Journal of Cardiovascular Drugs;2023-05-18

3. Applications of Quantitative Systems Pharmacology (QSP) in Drug Development for NAFLD and NASH and Its Regulatory Application;Pharmaceutical Research;2022-05-24

4. Quantitative Systems Toxicology and Drug Development: The DILIsym Experience;Methods in Molecular Biology;2022

5. Research status and progress of drug induced liver injury;World Chinese Journal of Digestology;2021-08-28